This invention is directed to 17β-(cyclopropylamino)androstenes and also to a method for using such compounds in the treatment of androgen-dependent disorders. The compounds are prepared by the hydride reduction of an appropriate steroidal imine or enamine.
-
(2008/06/13)
More Articles about upstream products of 120973-21-9